The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2019 | Patient-reported outcomes with CAR T-cell therapy
Surbhi Sidana
• 2 Jun 2019
Surbhi Sidana, MD, of the Mayo Clinic, Rochester, MN, talks about patient-reported outcomes (PROs) for patients undergoing CAR T-cell therapy at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.
